During the past decade, Milwaukee Eye Surgeons conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Milwaukee Eye Surgeons" are "Corneal Ulcer" (2 trials) and "Keratitis" (2 trials). Many other conditions were trialed in "Milwaukee Eye Surgeons" in a lesser frequency.

Most popular intervention types in "Milwaukee Eye Surgeons" are "Combination Product" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "PXL Platinum 330 system + Riboflavin 0.25% TE Solution" (1 trials), "Sham CXL + Artificial Tears" (1 trials), "Standard of Care Therapy + CXL + Riboflavin 0.23% L Solution" (1 trials) and "Standard of Care Therapy + Sham CXL + Artificial Tears" (1 trials). Other intervention names were less common.

The vast majority of trials in "Milwaukee Eye Surgeons" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Milwaukee Eye Surgeons". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Milwaukee Eye Surgeons, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Milwaukee Eye Surgeons, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".